[go: up one dir, main page]

MX2009008040A - Uso de arcillas para tratar la enfermedad celiaca. - Google Patents

Uso de arcillas para tratar la enfermedad celiaca.

Info

Publication number
MX2009008040A
MX2009008040A MX2009008040A MX2009008040A MX2009008040A MX 2009008040 A MX2009008040 A MX 2009008040A MX 2009008040 A MX2009008040 A MX 2009008040A MX 2009008040 A MX2009008040 A MX 2009008040A MX 2009008040 A MX2009008040 A MX 2009008040A
Authority
MX
Mexico
Prior art keywords
clay
coeliac disease
treating coeliac
treating
disease
Prior art date
Application number
MX2009008040A
Other languages
English (en)
Inventor
Helene Mathiex-Fortunet
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of MX2009008040A publication Critical patent/MX2009008040A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se relaciona con el uso de arcilla para la preparación de un fármaco para tratar la enfermedad celiaca. Preferentemente, la arcilla utilizada es del tipo esmectita.
MX2009008040A 2007-02-06 2008-02-06 Uso de arcillas para tratar la enfermedad celiaca. MX2009008040A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0700821A FR2912059B1 (fr) 2007-02-06 2007-02-06 Utilisation d'argiles pour le traitement de la maladie coeliaque
PCT/FR2008/000142 WO2008113905A1 (fr) 2007-02-06 2008-02-06 Utilisation d'argiles pour le traitement de la maladie coeliaque

Publications (1)

Publication Number Publication Date
MX2009008040A true MX2009008040A (es) 2009-08-07

Family

ID=38515715

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008040A MX2009008040A (es) 2007-02-06 2008-02-06 Uso de arcillas para tratar la enfermedad celiaca.

Country Status (12)

Country Link
US (2) US20100003348A1 (es)
EP (1) EP2117566B1 (es)
JP (1) JP2010518054A (es)
CN (1) CN101605551B (es)
AR (1) AR065215A1 (es)
BR (1) BRPI0807467A2 (es)
CA (1) CA2677404C (es)
ES (1) ES2610816T3 (es)
FR (1) FR2912059B1 (es)
MX (1) MX2009008040A (es)
RU (1) RU2519217C2 (es)
WO (1) WO2008113905A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2386289A1 (en) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Clay compositions
DE102012207471A1 (de) * 2012-05-04 2013-11-07 Fim Biotech Gmbh Mineralische Verbindung und deren Modifikationen zur Anwendung bei chronisch-entzündlichen Darmerkrankungen
US9836879B2 (en) * 2013-04-16 2017-12-05 Autodesk, Inc. Mesh skinning technique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512345D0 (en) * 1985-05-15 1985-06-19 Scras Anti-diarrhea compositions
IE77165B1 (en) * 1991-01-30 1997-12-03 Wellcome Found Water-dispersible tablet containing acyclovir
CN1326745A (zh) * 2000-06-01 2001-12-19 翟永功 蒙脱石为胃肠道药物的成份
DE10056634A1 (de) * 2000-11-15 2002-05-29 Sued Chemie Ag Verwendung Aktivierter Schichtsilicate zur Mykotoxinadsorption
CN100340235C (zh) * 2004-05-21 2007-10-03 山东绿叶制药有限公司 蒙脱石分散片及其制备工艺

Also Published As

Publication number Publication date
EP2117566A1 (fr) 2009-11-18
FR2912059A1 (fr) 2008-08-08
JP2010518054A (ja) 2010-05-27
CA2677404C (fr) 2015-07-07
EP2117566B1 (fr) 2016-10-19
CA2677404A1 (fr) 2008-09-25
CN101605551A (zh) 2009-12-16
ES2610816T3 (es) 2017-05-03
WO2008113905A1 (fr) 2008-09-25
FR2912059B1 (fr) 2013-04-05
US20130039999A1 (en) 2013-02-14
AR065215A1 (es) 2009-05-20
US20100003348A1 (en) 2010-01-07
CN101605551B (zh) 2013-04-03
RU2519217C2 (ru) 2014-06-10
BRPI0807467A2 (pt) 2014-05-20
RU2009133350A (ru) 2011-03-20

Similar Documents

Publication Publication Date Title
PL2150530T3 (pl) Podstawione pochodne sulfonamidu
HUS1600048I1 (hu) Készítmény Fabry-kór kezelésére
WO2010014836A3 (en) Tgr5 modulators and methods of use thereof
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
ZA200808178B (en) Imidazolothiazole compounds for the treatment of disease
CY1112067T1 (el) Χρηση φλιμπανσερινης για την θεραπεια διαταραχων προ-εμμηνοπαυσιακης σεξουαλικης επιθυμιας
UA102432C2 (ru) Цитотоксичные конъюгаты с соединением, которое связывает рецептор нейропептиду y
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
WO2009074247A8 (de) Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel
IL206277A0 (en) 1,2,4-oxadiazole compounds for the treatment of autoimmune diseases
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
PT2056805E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de reacção tecidular
EP2320939A4 (en) TISSUE CALLICLE FOR THE TREATMENT OF PARKINSON DISEASE
MX2009011999A (es) Extruidos con enmascaramiento del sabor mejorado.
EA200900261A1 (ru) Применение эсцина
EP2421554A4 (en) TISSUE KALLICREIN FOR THE TREATMENT OF HUNTINGTON'S DISEASE
MX2009008040A (es) Uso de arcillas para tratar la enfermedad celiaca.
EA200970816A1 (ru) Новая лекарственная форма
PH12017500270A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
EA200970969A1 (ru) Применение 4-циклопропилметокси-n-(3,5-дихлор-1-оксидопиридин-4-ил)-5-(метокси)пиридин-2-карбоксамида для лечения травм спинного мозга
MX2009012096A (es) Axomadol para tratamiento de dolor con artritis.
EA200970970A1 (ru) Применение 4-циклопропилметокси-n-(3,5-дихлор-1-оксидо-4-пиридин-4-ил)-5-(метокси)пиридин-2-карбоксамида для лечения моторных нарушений, связанных с болезнью паркинсона
UA96574C2 (ru) Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments

Legal Events

Date Code Title Description
FG Grant or registration